Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.39 USD | -1.18% |
|
+18.17% | +129.23% |
07-17 | Mind Medicine Says New Patent Secured for Investigational Anxiety Disorder Treatment MM120 | MT |
07-17 | Mind Medicine Inc. Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+129.23% | 603M | |
+24.74% | 47.54B | |
-0.47% | 41.96B | |
+48.83% | 41.55B | |
+25.40% | 30.36B | |
+17.96% | 27.61B | |
-4.47% | 28.7B | |
+50.73% | 14.7B | |
+42.56% | 13.51B | |
+1.46% | 12.34B |
- Stock Market
- Equities
- MNMD Stock
- News Mind Medicine (MindMed) Inc.
- RBC Raises Price Target on Mind Medicine (MindMed) to $7 From $5, Maintains Outperform, Speculative Risk